Association between genetic polymorphism of GSTT1 and GSTM1 and atopic status in children with BA Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis Year: 2009
Metabolic gene polymorphisms (CYP1A1, EPHX1, GSTM1 and GSTP1) associations with the severity of cystic fibfosis airway disease Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003
The influence of polymorphism of GSTT1 ,GSTM1, ACE genes on the development of BA in children Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis Year: 2009
The role of GSTT1 and GSTM1 gene polymorphisms in bronchial asthma Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018
Associations between genetic polymorphisms and drug response phenotypes in patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007
Association of NRAMP1 gene polymorphisms with COPD clinical signs Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018
Association of NRAMP1 gene polymorphisms with COPD clinical signs Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007
Analysis of association between the GSTT1 and GSTM1 genes polymorphism and asthma-associated traits (AAT) Source: Eur Respir J 2003; 22: Suppl. 45, 581s Year: 2003
HLA-DRB1 allele frequencies in Finnish sarcoidosis patients and associations with disease prognosis Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010
The influence of the polymorphism at codon 72 of exon 4 of the P53 gene and GSTM1 and GSTT1 null in lung cancer risk in a Brazilian population Source: Eur Respir J 2006; 28: Suppl. 50, 812s Year: 2006
The leucocyte telomere length, GSTM1 and GSTT1 null genotypes and the risk of COPD Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021
Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma Source: Eur Respir J 2004; 24: Suppl. 48, 136s Year: 2004
Study on relationship between the haplotypes of polymorphisms in β2 -AR and asthma Source: Eur Respir J 2005; 26: Suppl. 49, 282s Year: 2005
Genetic polymorphisms CYP1A1 m1 , GSTM1 , GSTT1 null and lung cancer susceptibility in a Brazilian population Source: Eur Respir J 2006; 28: Suppl. 50, 812s Year: 2006
IFNL3 polymorphisms are associated with COPD severity and outcomes Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017
Positive association of PPARG2 and PPARGC1A gene polymorphisms with sarcoidosis susceptibility Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007
The role of IL-18 level and genetic polymorphism in patients with bronchial asthma and its relation to disease severity Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012
Association of GSTT1, GSTM1 and CYP1A1 MSP1 gene polymorphism with lung cancer patients in north Indian population Source: Annual Congress 2010 - Epidemiology of lung cancer Year: 2010
GSTT1 null alleles are risk factors for excess FEV1 decline in the general population, but GSTM1 null alleles only in smokersSource: Eur Respir J 2007; 30: Suppl. 51, 447s Year: 2007
A single nucleotide polymorphism in NOD2 gene was associated with pathogenesis and severity of COPD Source: Annual Congress 2010 - Genetics of obstruction Year: 2010